ReproCELL Incorporated
Offers stem cell tech, gene editing & drug discovery services for preclinical/clinical research.
4978 | T
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- Japan
- Address:
- 横浜市港北区新横浜３−８−１１
- Website:
- https://www.reprocell.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
ReproCELL Incorporated is a global life sciences company providing products and services for preclinical and clinical research, with a focus on stem cell technology, drug discovery, and regenerative medicine. Established in 2003 as a pioneer in the field, the company offers a comprehensive portfolio that supports the entire research workflow. Key offerings include induced pluripotent stem cell (iPSC)-derived human cells, such as neurons and cardiomyocytes, clinical gene editing services, cell culture reagents, and end-to-end discovery platforms for neuroscience and immuno-oncology. ReproCELL serves scientists and pharmaceutical companies worldwide, aiming to accelerate the translation of research into novel therapies and improve human health.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for ReproCELL Incorporated and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-26 02:41 |
Regulatory News Service
内部統制報告書－第23期(2024/04/01－2025/03/31)
|
Japanese | 23.4 KB | |
| 2025-06-26 02:41 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2025-06-26 02:40 |
Annual Report
有価証券報告書－第23期(2024/04/01－2025/03/31)
|
Japanese | 1.1 MB | |
| 2024-11-13 07:31 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2024-11-13 07:31 |
Interim Report
半期報告書－第23期(2024/04/01－2025/03/31)
|
Japanese | 221.1 KB | |
| 2024-06-26 03:02 |
Regulatory News Service
臨時報告書
|
Japanese | 28.0 KB | |
| 2024-06-25 07:31 |
Regulatory News Service
内部統制報告書－第22期(2023/04/01－2024/03/31)
|
Japanese | 22.2 KB | |
| 2024-06-25 07:30 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-06-25 07:29 |
Annual Report
有価証券報告書－第22期(2023/04/01－2024/03/31)
|
Japanese | 1.2 MB | |
| 2024-05-23 08:02 |
Regulatory News Service
臨時報告書
|
Japanese | 20.0 KB | |
| 2024-02-09 07:24 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB | |
| 2024-02-09 07:23 |
Quarterly Report
四半期報告書－第22期第3四半期(2023/10/01－2023/12/31)
|
Japanese | 227.6 KB | |
| 2023-11-10 07:05 |
Quarterly Report
四半期報告書－第22期第2四半期(2023/07/01－2023/09/30)
|
Japanese | 213.2 KB | |
| 2023-11-10 07:03 |
Regulatory News Service
確認書
|
Japanese | 8.1 KB | |
| 2023-08-10 08:03 |
Regulatory News Service
確認書
|
Japanese | 8.2 KB |
Automate Your Workflow. Get a real-time feed of all ReproCELL Incorporated filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for ReproCELL Incorporated via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
